Best Nuclear Energy Stock to Buy Right Now: GE Vernova vs. BWX Technologies

GE Vernova and BWX Technologies are presented as profitable ways to play the nuclear energy buildout, with GEV reporting $38.1B in 2025 revenue and $4.9B in net income, and BWXT posting $3.1B in revenue and nearly $330M in net income. BWXT also raised its nuclear footprint via an $2.6B, eight-year Naval Nuclear Propulsion Program contract and expects 2026 revenue above $3.7B. The article is broadly constructive on both names, but it ultimately favors GE Vernova for its larger revenue base and broader growth opportunities.

Analysis

The market is mispricing nuclear exposure as a pure “future SMR optionality” trade, but the nearer-term earnings power is actually coming from regulated, high-barrier adjacent infrastructure. That shifts the center of gravity toward suppliers with government-backed backlog and away from pure-play reactor developers, whose cash flows remain hostage to permitting, first-of-a-kind execution, and financing windows that can slip multiple years.

GEV’s advantage is not just scale; it is that its SMR exposure is embedded inside a larger earnings engine, which dampens the binary risk that usually kills nuclear valuation multiples. The second-order effect is that GEV can use its balance-sheet credibility and industrial footprint to crowd out smaller entrants on supply-chain access, project financing, and customer trust, especially if data-center power demand remains the gating item for utility procurement.

BWXT is the cleaner scarcity asset, but the market may be underestimating how much of its value comes from defense and government-funded nuclear complexity rather than commercial reactor growth. That creates a more durable moat, yet also caps upside if investors start to view it as a slow-growth contractor instead of a “nuclear pure play.” The bigger catalyst is not reactor deployment headlines; it is contract conversion and manufacturing footprint expansion, which can re-rate margins before any SMR plant actually turns on.

The contrarian read is that the bullish setup is probably better for the ecosystem than for the headline SMR names. If commercialization keeps slipping, capital will continue to migrate to picks-and-shovels winners with current profits and visible backlog. The main reversal risk is not a collapse in nuclear demand, but a broader delay in power-hungry data-center buildouts or a policy-driven slowdown in SMR procurement, which would compress the longer-duration multiple on GEV first and leave BWXT comparatively resilient.

Key Decisions for Investors

• Long GEV on 6-12 month horizon; buy on any 8-10% drawdown. Risk/reward favors owning the profitable platform with SMR upside embedded, but size modestly because the multiple is sensitive to data-center capex sentiment.
• Long BWXT as the lower-beta nuclear compounder; hold 12+ months. Use as a relative-value hedge against SMR development slippage, with upside driven by backlog conversion and margin mix rather than project headlines.
• Pair trade: long BWXT / short OKLO or SMR for 3-9 months. Thesis is that capital will keep rewarding cash-generating suppliers over pre-revenue reactor stories if commercialization timelines stretch again.
• If initiating a nuclear basket, overweight GEV + BWXT over SMR/OKLO by at least 2:1. This captures current earnings plus optionality, while minimizing financing and execution risk.
• For tactical investors, consider selling out-of-the-money calls against GEV into strength. The stock can rerate on headlines, but the path is likely choppy because the next leg depends on project milestones, not just sector enthusiasm.